Bullboard - Stock Discussion Forum Intercept Pharmaceuticals Inc ICPT

Healthcare Biotechnology

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry. Its product candidates include Ocaliva (obeticholic (OCA)) for liver fibrosis due to nonalcoholic steatohepatitis (NASH), OCA and Bezafibrate, and Other... see more

Add To Watchlist

NDAQ:ICPT - Post Discussion

Intercept Pharmaceuticals Inc > 5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

View:

Post by AviseAnalytics on Feb 08, 2022 9:03am

5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS

$ICPT $CYTK $ADGI $PHAT $AGIO

Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table.

The covered Companies have major upcoming catalysts such as an impending FDA approval, drug launch, data readouts, initiation of clinical trials and IND submission to look forward to.

Learn More:
https://www.aviseanalytics.com/5-biotech-stocks-with-major-upcoming-catalysts/

130